N e p h r o l o g y
D e p a r t m e n t
H o s p i t a l
G a r c i a d e O r t a
1st
International
Caparica
Conference in
Translational
Nephrology
http://www.nephromics2014.com/
Sponsors:
NEPHROMICS 2014
Baxter
Genzyme
Novartis
Diaverum
Fresenius
Shire
OM Pharma
Amgen
Abbvie
O R G A N I Z E R S
- Nephrology Service , Hospital
Garcia de Orta, Portugal
- Bioscope Research Group
- FCT—UNL,Lisbon, Portugal
1 8 TH P ORTUGUESE
S YMPOSIUM IN
R E N AL D I S E AS E S :
“ F ROM – OMICS TO
C L I N I C AL
P R AC T I C E ”
10-11 Oct 2014
COSTA CAPARICA HOTEL
Day 1– Friday 10
Day 2 – Saturday 11
18th Portuguese Symposium in Renal Diseases
Nephromics 2014
09h00
Opening session
09h15
AKI –biomarkers in risk assessment and predicting
models
Pedro Ponce - Lisboa
Moderators:
João P Travassos
Ana Mateus
New advances in peritoneal dialysis: from
biomar kers to clinical practice
Anabela Rodrigues– Porto
Moderators:
Augusta Gaspar
Teixeira e Costa
10h00
10h45
coffee break
11h15
From -omics to personalized medicine in nephrology
Thomas Koeck–Hannover
Moderators:
Rui Alves
Aura Ramos
Lupus Nephritis: current update – from basics
to therapy
Hans-Joachim Anders – Munich
Moderators:
Pedro Ponce
Cristina Santos
Lunch
12h00
12h45
14h30
15h15
16h00
Indivivualizing therapy: Do geneticists have the
tools to predict which glomerulonephritis will go
wrong?
João Paulo Oliveira– Porto
Moderators:
Edgar Almeida
Joaquim Calado
Diabetic Nephropathy – predicting outcomes from
multiple markers
Michael Rudnicki–Innsbruck
Moderators:
Ana Paula Silva
Pedro Bravo
Tolerance in transplantation: Get, monitor, act
Ondrej Viklicky- Prague
Moderators:
Carlos Oliveira
Alice Santana
09h00
Opening session
09h15 - 10h00 Gert Mayer
‘The road to stratified medicine for diabetic nephropathy’
10h00 - 10h45 Chan-Wha Kim
Proteomic analysis of glomeruli from
steptozotocin-induced diabetic rats and glomerular
epithelial cells at hyperglycemia
10h45 - 11h30 Yamamoto Tadashi
´Application of Proteomics to Translational
Nephrology´
11h30 - 11h45 Youhe Gao
Discover Urinary Biomarkers for Kidney Disease
11h45 - 12h 30 Poster Session
12h45 - 14h30 Lunch
14h30 - 14h50 Chrishan S. Samuel
‘Profiling kidney repair to identify therapeutic strategies
for renal fibrosis’
14h50 - 15h10 Lambers Heerspink
Use of OMIC techniques to predict the response to
renin-angiotensin-aldosterone system intervention
15h55 - 16h10 Dr.GonçaloGraça/Joana Sousa
‘Metabolomics of human biofluids as a strategy
to assist diagnosis
16h10 - 16h25 Francisco J. López
New Concepts for Acute Kidney Injury Diagnosis
16h25 - coffee break
16h55 - 17h10 Ivana Markovic
Environment and proteome changes of kidney
tubular cells: pathophysiology of Endemic
nephropathy
17h10 - 17h25 Tzu-Ling Karen Tseng
DNlite: A Novel Technology for Management of
the Renal Complication in Diabetes
17h25 - 17h40 Mónica Roxo-Rosa
Identification of Polycystin-2 and CFTR common
targets – a step towards the understanding of the
Autosomal Dominant Polycystic Kidney Disease
17h40 - 17h55 Axel C. Carlsson
Soluble tumor necrosis factor receptor 1
(sTNFR1) is associated with glomerular filtration
rate progression and incidence of chronic kidney
disease in two community-based cohorts of elderly
15h10 - 15h25 Manoocher Soleimani
The Causal Role of Salt Wasting and Volume
Depletion in the Pathogenesis of Hypercalciuria and
Kidney Stone Generation
17h55 - 18h10 Dr. Gary Gerlach
Zebrafish pronephros tubulogenesis and epithelial
identity maintenance are reliant on the polarity
proteins Prkc iota and zeta
15h25 - 15h40 Marie PauleMingeot
Deciphering the cellular pathways of aminoglycoside
antibiotics nephrotoxicity, a valuable complementation
for “omics” based assessment of the drug toxicity?
18h10 - 18h15 Clara G. Dias
‘The role of Nevirapine phase I metabolites in
the renal function of HIV- infected patients.’
15h40 - 15h55 Annalisa Castagna
‘G en d er a n d s u b t y p e- s p ec i f ic al t er a t i o n s of
u r i n a r y m et a b ol i c p r o fil es i n p a t i en t s
a f f ec t ed b y p r im a ry al d o s t er o n i sm ’
18h15 - 18h20 Márcia de Jesus de Sá Monteiro
Analysis of urinary volatile metabolomic pattern as
a potential approach for the discrimination of renal
cell carcinoma (RCC) patients
18h30
Ending session